打开黑箱:整倍体囊胚为何着床失败?系统综述与Meta分析
该研究系统检索至2021年8月,纳入372篇原始研究和41篇综述,评估与整倍体囊胚活产率和流产率相关的胚胎、母体、父体、临床及IVF实验室特征。多数研究为回顾性且样本量小,证据质量低或极低。内细胞团或滋养外胚层质量差、囊胚质量低于Gardner BB级、发育延迟、某些形态动力学异常、高龄、肥胖、既往反复种植失败、多次玻璃化复苏周期、活检细胞数多与较差结局相关;玻璃化冻融移植优于新鲜移植,同时透明带开孔与滋养外胚层活检优于第3天孵化方案。
要点
- 内细胞团或滋养外胚层质量差、囊胚质量低于Gardner BB级、发育延迟与较差生殖结局相关。
- 高龄、肥胖、既往反复种植失败与整倍体囊胚活产率降低相关,肥胖还与流产率升高相关。
- 玻璃化冻融移植优于新鲜移植,同时透明带开孔与滋养外胚层活检优于第3天孵化方案。
核心结论
- 多种胚胎、母体、父体、临床及IVF实验室特征与整倍体囊胚的活产率和流产率相关。
- 多数研究为回顾性且样本量小,证据质量低或极低,未来需进一步研究以填补着床黑箱的空白。
研究设计与样本
- 系统综述与Meta分析,检索至2021年8月,纳入372篇原始研究(335篇回顾性研究、30篇前瞻性研究、7项随机对照试验)和41篇综述。
- 采用PRISMA指南、PICO模型、ROBINS-I和ROB 2.0评分评估偏倚,使用随机效应模型合并分类数据,采用I²评估异质性,并通过漏斗图和剪补法评估发表偏倚。
- 研究方案在PROSPERO注册(注册号CRD42021275329)。
主要发现
- 内细胞团减小(7项研究,OR 0.37,95%CI 0.27-0.52,I²=53%)、滋养外胚层质量差(9项研究,OR 0.53,95%CI 0.43-0.67,I²=70%)、囊胚整体质量差于Gardner BB级(8项研究,OR 0.40,95%CI 0.24-0.67,I²=83%)、发育延迟(18项研究,OR 0.56,95%CI 0.49-0.63,I²=47%)均与较差的生殖结局相关。
- 年龄≥38岁女性活产率略低(7项研究,OR 0.87,95%CI 0.75-1.00,I²=31%)。
- 肥胖与较低的活产率(2项研究,OR 0.66,95%CI 0.55-0.79,I²=0%)和较高的流产率(2项研究,OR 1.8,95%CI 1.08-2.99,I²=52%)相关。
- 既往反复种植失败与较低的活产率相关(3项研究,OR 0.72,95%CI 0.55-0.93,I²=0%)。
- 玻璃化冻融胚胎移植比新鲜移植更有效(2项研究,OR 1.56,95%CI 1.05-2.33,I²=23%),多次玻璃化复苏周期可能降低活产率(2项研究,OR 0.41,95%CI 0.22-0.77,I²=50%),同时透明带开孔与滋养外胚层活检比第3天孵化方案结果更好(3项研究,OR 1.41,95%CI 1.18-1.69,I²=0%)。
临床怎么用
- 作者认为,了解与整倍体囊胚生殖能力相关的特征对于定义、实施和验证更安全有效的临床工作流程至关重要。
- 作者建议未来研究应针对:生殖衰老机制的系统研究、子宫和囊胚-内膜对话的评估、胚胎评估和IVF方案的标准化/自动化、以及额外的侵入性或非侵入性胚胎选择工具。
局限性
- 大多数研究为回顾性研究或样本量小,易产生偏倚,导致证据质量降低至低或极低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A normal chromosomal constitution defined through PGT-A assessing all chromosomes on trophectoderm (TE) biopsies represents the strongest predictor of embryo implantation. Yet, its positive predictive value is not higher than 50-60%. This gap of knowledge on the causes of euploid blastocysts' reproductive failure is known as 'the black box of implantation'. OBJECTIVE AND RATIONALE: Several embryonic, maternal, paternal, clinical, and IVF laboratory features were scrutinized for their putative association with reproductive success or implantation failure of euploid blastocysts. SEARCH METHODS: A systematic bibliographical search was conducted without temporal limits up to August 2021. The keywords were '(blastocyst OR day5 embryo OR day6 embryo OR day7 embryo) AND (euploid OR chromosomally normal OR preimplantation genetic testing) AND (implantation OR implantation failure OR miscarriage OR abortion OR live birth OR biochemical pregnancy OR recurrent implantation failure)'. Overall, 1608 items were identified and screened. We included all prospective or retrospective clinical studies and randomized-controlled-trials (RCTs) that assessed any feature associated with live-birth rates (LBR) and/or miscarriage rates (MR) among non-mosaic euploid blastocyst transfer after TE biopsy and PGT-A. In total, 41 reviews and 372 papers were selected, clustered according to a common focus, and thoroughly reviewed. The PRISMA guideline was followed, the PICO model was adopted, and ROBINS-I and ROB 2.0 scoring were used to assess putative bias. Bias across studies regarding the LBR was also assessed using visual inspection of funnel plots and the trim and fill method. Categorical data were combined with a pooled-OR. The random-effect model was used to conduct the meta-analysis. Between-study heterogeneity was addressed using I2. Whenever not suitable for the meta-analysis, the included studies were simply described for their results. The study protocol was registered at http://www.crd.york.ac.uk/PROSPERO/ (registration number CRD42021275329). OUTCOMES: We included 372 original papers (335 retrospective studies, 30 prospective studies and 7 RCTs) and 41 reviews. However, most of the studies were retrospective, or characterized by small sample sizes, thus prone to bias, which reduces the quality of the evidence to low or very low. Reduced inner cell mass (7 studies, OR: 0.37, 95% CI: 0.27-0.52, I2 = 53%), or TE quality (9 studies, OR: 0.53, 95% CI: 0.43-0.67, I2 = 70%), overall blastocyst quality worse than Gardner's BB-grade (8 studies, OR: 0.40, 95% CI: 0.24-0.67, I2 = 83%), developmental delay (18 studies, OR: 0.56, 95% CI: 0.49-0.63, I2 = 47%), and (by qualitative analysis) some morphodynamic abnormalities pinpointed through time-lapse microscopy (abnormal cleavage patterns, spontaneous blastocyst collapse, longer time of morula formation I, time of blastulation (tB), and duration of blastulation) were all associated with poorer reproductive outcomes. Slightly lower LBR, even in the context of PGT-A, was reported among women ≥38 years (7 studies, OR: 0.87, 95% CI: 0.75-1.00, I2 = 31%), while obesity was associated with both lower LBR (2 studies, OR: 0.66, 95% CI: 0.55-0.79, I2 = 0%) and higher MR (2 studies, OR: 1.8, 95% CI: 1.08-2.99, I2 = 52%). The experience of previous repeated implantation failures (RIF) was also associated with lower LBR (3 studies, OR: 0.72, 95% CI: 0.55-0.93, I2 = 0%). By qualitative analysis, among hormonal assessments, only abnormal progesterone levels prior to transfer were associated with LBR and MR after PGT-A. Among the clinical protocols used, vitrified-warmed embryo transfer was more effective than fresh transfer (2 studies, OR: 1.56, 95% CI: 1.05-2.33, I2 = 23%) after PGT-A. Lastly, multiple vitrification-warming cycles (2 studies, OR: 0.41, 95% CI: 0.22-0.77, I2 = 50%) or (by qualitative analysis) a high number of cells biopsied may slightly reduce the LBR, while simultaneous zona-pellucida opening and TE biopsy allowed better results than the Day 3 hatching-based protocol (3 studies, OR: 1.41, 95% CI: 1.18-1.69, I2 = 0%). WIDER IMPLICATIONS: Embryo selection aims at shortening the time-to-pregnancy, while minimizing the reproductive risks. Knowing which features are associated with the reproductive competence of euploid blastocysts is therefore critical to define, implement, and validate safer and more efficient clinical workflows. Future research should be directed towards: (i) systematic investigations of the mechanisms involved in reproductive aging beyond de novo chromosomal abnormalities, and how lifestyle and nutrition may accelerate or exacerbate their consequences; (ii) improved evaluation of the uterine and blastocyst-endometrial dialogue, both of which represent black boxes themselves; (iii) standardization/automation of embryo assessment and IVF protocols; (iv) additional invasive or preferably non-invasive tools for embryo selection. Only by filling these gaps we may finally crack the riddle behind 'the black box of implantation'.
引用
- Cimadomo D, Rienzi L, Conforti A, et al. Opening the black box: why do euploid blastocysts fail to implant? A systematic review and meta-analysis. Hum Reprod Update. 2023. PMID: 37192834. doi:10.1093/humupd/dmad010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。